Back to Agenda
Session 3: Parallel Scientific Advice & Early Dialogue - Role Play on Mini Scientific Parallel Advice
Session Chair(s)
Anja Schiel, PhD
Special Advisor, Lead Methodologist; Leader international HTA (iHTA) NoMA
Norwegian Medicines Agency (NoMA), Norway
Giovanni Tafuri, PhD, MS
Senior Scientific Officer
EUnetHTA, Netherlands
This session is a role-play exercise where the Participants are encouraged to take different Stakeholders perspectives and discuss hypothetical products. By standing in someone else’s shoes, we hope that the challenges related to try to find the most optimal solution to satisfy all Stakeholders requests become clear.
Speaker(s)
Panel Discussion with the participation of: Industry Perspective
Vanessa Elisabeth Schaub
F. Hoffmann-La Roche, Switzerland
Global Access Senior Health Systems Strategy Leader HTA & Reimbursement
Payers Perspective
Erik Sagdahl
Norwegian Hospital Procurement Trust - Division of Pharmaceuticals, Norway
Advisor
Regulatory Perspective
Peter Mol, PharmD, PhD
MEB, Netherlands
CHMP member, NL
Patients Perspective
Matteo Scarabelli
EURORDIS, France
Patient Engagement Manager in HTA
Have an account?